< Back to catalogue
Vortioxetine
August 5, 2026Ceretec™
September 9, 2026PHARMAZAC
Myoview™
Tetrofosmin | Molecular Imaging | Radiopharmaceuticals
MYOVIEW LY.PD.INJ 0,23MG/VIAL(KIT)
MYOVIEW LY.PD.INJ 0,23MG/VIAL(KIT)
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
